Report overview
Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.
This report contains market size and forecasts of Viral Hepatitis and Retrovirus Diagnostic Tests in Global, including the following market information:
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Viral Hepatitis and Retrovirus Diagnostic Tests market was valued at 3717 million in 2021 and is projected to reach US$ 6015.8 million by 2028, at a CAGR of 7.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Hepatitis Diagnostic Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viral Hepatitis and Retrovirus Diagnostic Tests include Abbott Diagnostics, Abbott, Chembio, DiaSorin, Roche Diagnostics, Amkay Products, AOV International, Apothecaries Sundries Manufacturing and Beckman Coulter, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Hepatitis and Retrovirus Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
Viral Hepatitis Diagnostic Tests
Retrovirus Diagnostic Tests
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Nursing
Others
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Hepatitis and Retrovirus Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Viral Hepatitis and Retrovirus Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Diagnostics
Abbott
Chembio
DiaSorin
Roche Diagnostics
Amkay Products
AOV International
Apothecaries Sundries Manufacturing
Beckman Coulter
BD
Bhat Bio-tech
BioMerieux
Bioneovan
Bio-Rad
Cepheid
Enzo Biochem
Fujirebio
Gemc Technology
Grifols
Hangzhou Deangel Biological Engineering
Hangzhou Heo Bio-Tech
Hologic
Horiba
Innovation Biotech
Jaksh Enterprises
Krishco Medical Products
